Citation Impact

Citing Papers

The anti‐interleukin‐6 antibody siltuximab down‐regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
2011
Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer
2008
The donor–acceptor biphenyl platform: A versatile chromophore for the engineering of highly efficient two-photon sensitive photoremovable protecting groups
2012
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?
2013 Standout
Visible light driven room temperature Pauson–Khand reaction
2009 StandoutNobel
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates
2007
Water‐Soluble, Donor–Acceptor Biphenyl Derivatives in the 2‐(o‐Nitrophenyl)propyl Series: Highly Efficient Two‐Photon Uncaging of the Neurotransmitter γ‐Aminobutyric Acid at λ=800 nm
2012
Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases
2008
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Metal–Organic Frameworks as A Tunable Platform for Designing Functional Molecular Materials
2013 Standout
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Scaffold Diversity through Intramolecular Cascade Reactions of Solid-Supported Cyclic N-Acyliminium Intermediates
2007 StandoutNobel
Optimization of Hydroxybenzothiazoles as Novel Potent and Selective Inhibitors of 17β-HSD1
2012
Estrogen Metabolite 2-Methoxyestradiol Induces Apoptosis and Inhibits Cell Proliferation and Collagen Production in Rat and Human Leiomyoma Cells: A Potential Medicinal Treatment for Uterine Fibroids
2006 Standout
Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-(m-carbamoylbenzyl)-estradiol Derivatives
2013
Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
2008
Synthesis, Structures, and Properties of 1,2,4,5-Benzenetetrathiolate Linked Group 10 Metal Complexes
2009
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
2015 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Comprehensive Survey of Combinatorial Library Synthesis:  2005
2006
Development of intermolecular additive free Pauson–Khand reactions for estrone E-ring extension using microwaves
2008
New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity
2009
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Biochemical Factors Governing the Steady-State Estrone/Estradiol Ratios Catalyzed by Human 17β-Hydroxysteroid Dehydrogenases Types 1 and 2 in HEK-293 Cells
2009
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Discovery of Nonsteroidal 17β-Hydroxysteroid Dehydrogenase 1 Inhibitors by Pharmacophore-Based Screening of Virtual Compound Libraries
2008

Works of G.M. Allan being referenced

Focused Libraries of 16‐Substituted Estrone Derivatives and Modified E‐Ring Steroids: Inhibitors of 17ß‐Hydroxysteroid Dehydrogenase Type 1
2006
17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer
2008
Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1: Templates for design
2008
The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancer
2006
Novel, potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1
2005
Novel and Potent 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
2005
Further studies on dialkyltin 1,3-dithiole-2-thione-4,5-dithiolates, R2Sn(dmit). Crystal structures of orthorhombic- and monoclinic-Et2Sn(dmit), and Me2Sn(dmit)
2001
E-Ring Modified Steroids as Novel Potent Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
2005
Modification of Estrone at the 6, 16, and 17 Positions:  Novel Potent Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
2006
Rankless by CCL
2026